Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Azenta, Inc. - Common Stock (NQ:AZTA)

33.61 +0.35 (+1.06%)
Streaming Delayed Price Updated: 9:33 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
1 High-Flying Stock with Impressive Fundamentals and 2 We Find Risky
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings?
Azenta trades at $34.56 and has moved in lockstep with the market. Its shares have returned 12.3% over the last six months while the S&P 500 has gained 11.7%. 
Via StockStory
Topics Economy Stocks
News headline image
3 Overrated Stocks We Steer Clear Of
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
Corporate Maneuvers: Buybacks Signal Confidence, Insider Trades Spark Scrutiny
In a dynamic period for the financial markets, several public companies are making headlines with significant corporate actions. Azenta Inc. (NASDAQ: AZTA) and Fabasoft AG (XTRA: FSY) have recently... 
Via MarketMinute
Topics Law Enforcement Regulatory Compliance
News headline image
Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide ↗
A major earnings reset and fresh fund interest could mark a turning point for this formerly high-flying life-sciences stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We’re Skeptical Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand,... 
Via StockStory
Topics Stocks
News headline image
Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta (NASDAQ:AZTA) and its peers. 
Via StockStory
News headline image
Why Azenta (AZTA) Stock Is Trading Up Today
Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 4.2% in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion
Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per... 
Via StockStory
News headline image
Why Azenta (AZTA) Stock Is Up Today
Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 14.9% in the afternoon session after it reported third-quarter 2025 results that featured better-than-expected revenue and profitability. 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Which stocks are gapping on Friday? ↗
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Azenta Inc (NASDAQ:AZTA) Reports Q4 2025 Earnings Beat and Positive Market Reaction ↗
Azenta (AZTA) reports Q4 FY2025 results, beating EPS estimates with $0.21 and slightly missing on revenue. The stock rose on the positive earnings news. 
Via Chartmill
Topics Earnings
News headline image
Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales
Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per... 
Via StockStory
News headline image
Earnings Outlook For Azenta ↗
 
Via Benzinga
News headline image
Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings
Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Friday before the bell. Here’s what to look for. 
Via StockStory
News headline image
3 Unprofitable Stocks We’re Skeptical Of
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
1 Stock Under $50 for Long-Term Investors and 2 We Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
1 High-Flying Stock with Promising Prospects and 2 That Underwhelm
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
3 Russell 2000 Stocks We Think Twice About
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
This Coinbase Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Economy Stocks
News headline image
LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
3 Stocks Under $50 We’re Skeptical Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Topics Supply Chain
News headline image
Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2
Let’s dig into the relative performance of Azenta (NASDAQ:AZTA) and its peers as we unravel the now-completed Q2 drug development inputs & services earnings season. 
Via StockStory
News headline image
Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
News headline image
3 Unprofitable Stocks We Steer Clear Of
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Earnings Economy
News headline image
AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter
Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year on year at $143.9 million. Its non-GAAP profit of $0.14 per share was in... 
Via StockStory
Topics Economy
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.